Join us for the upcoming o2h ChaiTime Webinar, where our expert panellists will discuss how MFN pricing could reshape R&D strategies, operations, decision-making for biotech and pharma.
The biopharma landscape is shifting fast, driven by evolving pricing policies, geopolitical trade tensions, and mounting pressure to optimise R&D investment. With the recent push toward nation-based drug pricing, global companies are being forced to rethink not just pricing models, but where and how they innovate.
A candid conversation with industry experts on how these policy changes are impacting R&D pipelines, funding strategies, and outsourcing decisions.
If you’re leading R&D, shaping strategy, or navigating the evolving biotech landscape, you would not want to miss this.
๐ ๐ฅ๐ฒ๐๐ฒ๐ฟ๐๐ฒ ๐๐ผ๐๐ฟ ๐๐ฝ๐ผ๐ ๐ป๐ผ๐: https://us02web.zoom.us/webinar/register/7717513742014/WN_qHqcSgRASECAqSHCC4lmCw
๐๐ฎ๐๐ฒ: Friday, 11th July 2025
๐ง๐ถ๐บ๐ฒ: 3:00 PM – 4:00 PM GMT
๐ฃ๐น๐ฎ๐๐ณ๐ผ๐ฟ๐บ: Live on Zoom